卒中发病地点对血管内取栓疗效的影响:院内卒中与社区卒中的结局比较
单中心回顾性队列研究纳入2015年1月1日至2021年4月30日676例发病12小时内接受血管内取栓的急性缺血性卒中患者,比较院内卒中(69例,10%)与社区卒中的时间指标、再通率和90天功能结局。院内卒中患者从识别到影像的时间更快(中位70分钟 vs 121分钟,P < .001),但溶栓率更低(25% vs 68%,P < .001),两组成功再通率及90天mRS无显著差异,院内卒中组院内死亡有升高趋势(P = .06)。
要点
- 院内卒中患者从识别到影像的时间显著快于社区卒中(中位70分钟 vs 121分钟,P < .001)。
- 院内卒中患者溶栓率低于社区卒中(25% vs 68%,P < .001),但两组成功再通率均>75%(P = .39)。
- 两组90天mRS无显著差异,院内卒中组院内死亡有升高趋势(P = .06)。
核心结论
- 院内卒中患者启动血管内取栓的工作流延迟较社区卒中更短,成功再通率和临床结局相似;90天死亡率和mRS评分在两组间等效。
研究设计与样本
- 单中心回顾性队列研究,纳入2015年1月1日至2021年4月30日676例年龄>18岁、发病12小时内接受血管内取栓的急性缺血性卒中患者,分为院内卒中组(69例,10%)和社区卒中组。
诊断标准与关键数值
- 成功再通定义为成功再灌注,两组均>75%(P = .39)。
- 功能结局采用90天mRS评分,良好结局定义为mRS 0-2。
- 出院时NIHSS评分中位数两组均<4(P = .18)。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Previous studies have suggested that patients experiencing an in-hospital stroke may face delays in treatment and worse outcomes compared with patients with community-onset strokes. However, most studies occurred when IV thrombolysis was the primary treatment. This study aimed to examine the outcomes of patients experiencing an in-hospital stroke in the endovascular thrombectomy era.
MATERIALS AND METHODS: This was a single-center retrospective cohort study of patients older than 18 years of age with acute ischemic stroke treated with endovascular thrombectomy within 12 hours of stroke onset from January 1, 2015, to April 30, 2021. Patients were classified into 2 groups: in-hospital strokes and community-onset strokes. We compared the time metrics of stroke care delivery, the rate of successful reperfusion, and functional outcome as scored using the mRS score at 90 days (favorable outcome was defined as mRS 0-2). Differences in proportions were assessed using the Fisher exact and χ2 tests as appropriate. For continuous variables, differences in medians between groups were evaluated using Mann-Whitney U tests.
RESULTS: A total of 676 consecutive patients were included, with 69 (10%) comprising the in-hospital stroke group. Patients experiencing in-hospital stroke were more likely to have diabetes (36% versus 18%, P = .02) and less likely to receive thrombolysis (25% versus 68%, P < .001) than those in the community-onset stroke group, but they were otherwise similar. Patients with in-hospital stroke had significantly faster overall time metrics, most notably from stroke recognition to imaging (median, 70 [interquartile range, 38-141] minutes versus 121 [74-228] minutes, P < .001). Successful recanalization was achieved in >75% in both groups (P = .39), with a median NIHSS score at discharge of <4 (P = .18). The 90-day mRS was similar in both groups, with a trend toward higher in-hospital mortality in the in-hospital stroke group (P = .06).
CONCLUSIONS: Patients with in-hospital stroke had shorter workflow delays to initiation of endovascular thrombectomy compared with their community counterparts but with a similar rate of successful recanalization and clinical outcomes. Most important, 90-day mortality and mRS scores were equivalent between in-hospital stroke and community-onset stroke groups.
引用
- Puac-Polanco P, Subasinghe S, Omid-Fard N, et al. Influence of Stroke-Onset Location on the Efficacy of Endovascular Thrombectomy: Comparison of Outcomes between In-Hospital versus Community-Onset Strokes. AJNR Am J Neuroradiol. 2024. PMID: 38816016. doi:10.3174/ajnr.A8362
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。